Most 70-year-olds diagnosed with stage 3 chronic kidney disease (CKD) will live for many years, and the large majority will never need dialysis. In a cohort study tracking older adults with CKD over nearly a decade, only about 5% progressed to end-stage kidney failure, while 61% died of unrelated causes, mostly cardiovascular disease.1PubMed Central. Chronic kidney disease and the risk of end-stage renal disease versus death That ratio tells the real story: for someone in their seventies, stage 3 CKD is overwhelmingly a marker of elevated cardiovascular risk rather than a countdown to dialysis. But the range of possible outcomes is wide, and it hinges on details that a single stage number does not capture.
Why Kidney Failure Is Not the Main Threat
The most reassuring finding for older adults with stage 3 CKD is how lopsided the numbers are. In that same large study, the rate of progression to end-stage kidney failure was just 0.5 per 100 person-years, while the rate of death from any cause was 6.8 per 100 person-years. Older adults with CKD were roughly 13 times more likely to die of something else than to reach the point where dialysis would be needed.1PubMed Central. Chronic kidney disease and the risk of end-stage renal disease versus death Cardiovascular disease accounted for nearly half of those deaths. This means the medical priorities for a 70-year-old with stage 3 CKD tend to look a lot like good general health management: controlling blood pressure, managing cholesterol, and staying physically active.
This does not mean the kidney diagnosis is irrelevant. CKD independently raises cardiovascular risk, and the kidneys can worsen faster in certain people. But for the average person in this age group, the practical question shifts from “when will my kidneys fail?” to “how do I protect my heart and slow things down?”
Stage 3a Versus 3b Makes a Real Difference
Stage 3 CKD covers a surprisingly broad range of kidney function. It is split into two sub-stages: 3a, where the estimated glomerular filtration rate (eGFR) falls between 45 and 59, and 3b, where it drops to 30-44. That gap is clinically meaningful. People at the 3a end often have a kidney function level that overlaps with normal aging, while those at 3b face higher risks of complications and faster progression.
Research on elderly patients with high blood pressure found that those with stage 3b CKD had measurably worse cognitive function than those with 3a, and the odds of cognitive impairment roughly doubled going from 3a to 3b.2Nephrology Dialysis Transplantation. #3044 Cognitive functions in elderly and senile patients with arterial hypertension, depending on the presence of concomitant chronic kidney disease stage 3A and 3B This pattern holds for other outcomes too. If your doctor tells you that you have stage 3 CKD, it is worth asking which sub-stage you fall into, because the outlook at an eGFR of 55 is meaningfully different from an eGFR of 32.
Proteinuria Changes the Picture Dramatically
The single most important modifier of prognosis in stage 3 CKD is not the eGFR number itself but whether protein is spilling into the urine. Proteinuria (or its more specific measurement, albuminuria) signals ongoing kidney damage that goes beyond the slow decline of aging. A matched cohort study looking at adults aged 65-79 found that those who had both reduced kidney function and proteinuria lost an estimated 8.3 years of life compared to matched controls, and their risk of dying from any cause was roughly three times higher.3Preventive Medicine Reports. Mortality risk and years of life lost for people with reduced renal function detected from regular health checkup: A matched cohort study
By contrast, someone with a low eGFR but no protein in the urine has a much gentler trajectory. This is why routine urine testing matters so much. If you have been told you have stage 3 CKD, ask about your urine albumin-to-creatinine ratio. A normal or mildly elevated result is genuinely good news. A high result means more aggressive treatment is warranted, and sooner.
How Much of This Is Just Normal Aging?
One of the most debated questions in nephrology is whether a low eGFR in a 70-year-old represents disease or the natural consequence of getting older. There is solid physiological evidence that kidneys decline with age even in healthy people. Renal blood flow drops by about 10% per decade starting around age 30, and the number of functioning filtering units gradually shrinks over a lifetime.4PubMed Central. Rate of decline in kidney function with age: a systematic review These changes happen in otherwise healthy adults and are amplified by conditions like high blood pressure and diabetes.
This matters for how you interpret a stage 3a diagnosis at age 70. A person with an eGFR of 55, no proteinuria, stable readings over time, and well-controlled blood pressure may simply be experiencing the expected trajectory of kidney aging. Their outlook is very different from someone the same age whose eGFR has fallen from 70 to 45 over two years with rising protein in the urine. The trend of the numbers over time tells you more than any single reading. A stable eGFR, even at a modestly low level, is far more reassuring than one that is declining rapidly.
Blood Pressure Management
Controlling blood pressure is the single most impactful thing you can do to slow kidney decline and reduce cardiovascular risk with stage 3 CKD. A review of the evidence found that getting blood pressure below 140/90 is a reasonable target for most people with stage 3 or 4 CKD. For those with significant proteinuria (more than a gram per day), aiming for a systolic pressure of 120-130 offered even greater benefit.5PubMed. What is the ideal blood pressure goal for patients with stage III or higher chronic kidney disease?
The catch for older adults is that pushing blood pressure too low can cause problems of its own, including dizziness, falls, and paradoxically worse cardiovascular outcomes. The evidence on ideal targets for elderly patients with CKD is genuinely conflicting: some studies show benefit from aggressive lowering, while others find that higher targets produce better results in this age group.6Systemic Hypertension. Target levels of blood pressure in the elderly and very old patients with chronic kidney disease without frailty This is one area where cookie-cutter guidelines fall short and individual assessment with your doctor genuinely matters.
Medications That Can Slow Progression
Two classes of medication have the most evidence behind them for protecting kidneys in older adults with CKD. The first includes ACE inhibitors and angiotensin receptor blockers (ARBs), which are blood pressure drugs that also reduce the strain on kidney filters. A large study of CKD patients averaging 75 years old found that those taking an ACE inhibitor or ARB had roughly a 19% lower risk of dying during follow-up compared to those who did not.7PubMed Central. Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease That benefit held across all examined subgroups, including the oldest patients.
However, the picture becomes less clear once CKD is more advanced. A study focused specifically on advanced CKD found no measurable difference in the risk of kidney failure or death across different patterns of ACE inhibitor or ARB use.8PubMed Central. ACE Inhibitor/Angiotensin Receptor Blocker Use Patterns in Advanced CKD and Risk of Kidney Failure and Death The practical takeaway is that these medications appear most beneficial earlier in the disease and that stopping or adjusting them later on may sometimes be the right call.
The second class, SGLT2 inhibitors, has generated a lot of excitement in nephrology over the past few years. Originally developed for diabetes, these drugs have shown kidney-protective effects that appear to hold even in people without diabetes. In a real-world Japanese study of older patients with diabetic kidney disease, those on SGLT2 inhibitors lost kidney function at less than half the rate of those on other diabetes medications: about 0.8 points of eGFR per year versus 1.8 points.9PubMed Central. Kidney outcomes of SGLT2 inhibitors among older patients with diabetic kidney disease in real-world clinical practice A narrative review confirmed that these benefits extend to elderly patients aged 75 and over, regardless of whether they have diabetes.10PubMed. SGLT2 Inhibitors and Outcomes in Elderly Patients With Chronic Kidney Disease: A Narrative Review If you have stage 3 CKD and are not already on one of these medications, it is worth discussing with your nephrologist.
Polypharmacy and Drugs That Can Hurt the Kidneys
Older adults with CKD tend to be on a lot of medications, and the medications themselves can contribute to further kidney decline. A prospective study of community-dwelling adults aged 60 and over found that each additional medication at baseline was associated with a drop of about 0.6 points of eGFR over two years. Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen were especially damaging, with each NSAID taken cumulatively associated with a decline of about 1.2 eGFR points over the same period.11ScienceDirect / Elsevier (J Am Med Dir Assoc). Polypharmacy and Kidney Function in Community-Dwelling Adults Age 60 Years and Older: A Prospective Observational Study
For someone whose eGFR is already in stage 3 territory, those small annual drops add up. The most common offenders include over-the-counter NSAIDs, certain antibiotics, proton pump inhibitors taken long-term, and some contrast dyes used in imaging. If you are managing CKD, it is genuinely useful to bring every medication, supplement, and over-the-counter pill to each appointment and ask whether each one is still appropriate given your kidney function.
Acute Kidney Injury Can Accelerate the Timeline
One of the biggest risks for an older person with stage 3 CKD is an episode of acute kidney injury (AKI), a sudden drop in kidney function typically triggered by dehydration, infection, surgery, or a new medication. AKI is common in hospitalized older adults, and it has been linked to faster progression toward advanced CKD and higher short-term mortality. A study of elderly patients found that those with AKI lasting more than seven days had six times the mortality risk within 90 days and seven times the odds of developing new chronic kidney disease compared to those with shorter episodes.12PubMed Central. Duration of acute kidney injury predicts 90-day mortality and chronic kidney disease progression in elderly patients
Multiple studies confirm that survivors of AKI are at high risk for progression to advanced CKD, with older age, diabetes, low baseline kidney function, and severe AKI episodes all identified as risk factors.13PubMed. Acute Kidney Injury Leading to Chronic Kidney Disease and Long-Term Outcomes of Acute Kidney Injury: The Best Opportunity to Mitigate Acute Kidney Injury? The practical lesson is that preventing these episodes matters enormously. Staying hydrated during illness, avoiding nephrotoxic drugs, and making sure your kidney function is monitored during and after any hospitalization can meaningfully change your long-term trajectory.
Frailty Matters More Than the Kidney Numbers Alone
Among older adults with advanced CKD, frailty is a powerful predictor of outcomes that often gets overlooked in conversations focused solely on eGFR and lab values. A prospective study of older CKD patients found that nearly half of frail patients also had severe cognitive impairment, compared to about 15% of non-frail patients.14PubMed Central. The Impact of Frailty and Severe Cognitive Impairment on Survival Time and Time to Initiate Dialysis in Older Adults With Advanced Chronic Kidney Disease Frailty captures something that lab values do not: overall physiological reserve, the body’s ability to bounce back from stress.
This has real implications for treatment decisions. For a frail 70-year-old whose CKD does eventually progress toward kidney failure, dialysis may not improve either quality or length of life. Conservative, non-dialytic management focused on symptom control and comfort can be a legitimate choice, and guidelines recommend that it be discussed openly with patients in this situation. The question is not just “how long can you live with CKD” but “what approach will give you the best quality of life for the years you have?”
Exercise and Physical Function
Physical activity is one of the more straightforward ways for older adults with CKD to improve their daily function and quality of life. Research in patients with advanced CKD averaging 75 years old has shown that individualized exercise training produces meaningful improvements in walking distance, muscle strength, and endurance, with gains comparable to those seen in healthy older adults doing the same exercises.15PubMed Central. Exercise training in chronic kidney disease—effects, expectations and adherence Home-based walking programs, even modest ones, have improved both physical capacity and quality-of-life scores in randomized trials of older CKD patients.
The benefit here is not necessarily about changing the eGFR trajectory, though some evidence suggests exercise may help with that too. The clearer benefit is functional: maintaining the ability to walk, climb stairs, and manage daily activities independently. For a 70-year-old, preserving that independence may matter more than any lab value. Even a simple program of regular walking, started slowly and built up over time, appears to make a measurable difference.
Bone Health and Fracture Risk
CKD disrupts the body’s handling of calcium, phosphorus, and vitamin D in ways that weaken bones. Between 18% and 32% of CKD patients also have osteoporosis, and people with CKD are more than 2.5 times as likely to suffer a fracture compared to those without it.16PubMed Central. Fracture Risk in Chronic Kidney Disease: Addressing an Overlooked Complication For a 70-year-old, a hip fracture can be a life-altering event with its own high mortality rate, making bone health an important part of managing CKD even though it gets less attention than kidney function itself.
The challenge is that CKD-related bone disease does not always look like typical osteoporosis, and standard osteoporosis treatments need careful consideration when kidney function is reduced. Some common supplements and medications are processed by the kidneys and may require dose adjustment or alternatives. If you have stage 3 CKD, a conversation about bone density screening and vitamin D levels is worth having, particularly if you have other risk factors for fractures like low body weight, a history of falls, or long-term steroid use.
Why Kidney Failure Risk Calculators Can Mislead Older Adults
Nephrologists often use the Kidney Failure Risk Equation (KFRE) to estimate the probability that a patient will need dialysis within two or five years. The tool works reasonably well for younger and middle-aged adults, but it overestimates the risk for the oldest patients. A study evaluating the KFRE in patients aged 80 and over found that it overpredicted kidney failure risk by about 23% at two years and 40% at five years.17PubMed Central. The Effect of Age on Performance of the Kidney Failure Risk Equation in Advanced CKD The overestimation was worst in those predicted to be at highest risk.
The reason ties back to competing risks. Models that predict kidney failure without accounting for the fact that older patients are more likely to die of something else first will systematically inflate the kidney-specific risk. If you have been given a KFRE score and it sounds alarming, it is reasonable to ask your doctor whether that number accounts for your age and overall health. In many cases, the actual probability of needing dialysis is lower than the calculator suggests, sometimes substantially so.
When CKD Affects Thinking and Memory
Cognitive decline is an underappreciated complication of CKD in older adults. The same factors that damage kidneys, including high blood pressure, diabetes, and vascular disease, also harm the brain. Research on elderly patients with hypertension found that those with stage 3b CKD had significantly worse scores on standard cognitive screening tests than those with 3a or no CKD, and the worsening tracked with CKD severity.2Nephrology Dialysis Transplantation. #3044 Cognitive functions in elderly and senile patients with arterial hypertension, depending on the presence of concomitant chronic kidney disease stage 3A and 3B The odds of meaningful cognitive impairment were roughly three to five times higher in patients with CKD compared to those without it.
This connection matters because cognitive decline can make it harder to manage medications, follow dietary recommendations, and attend appointments, all of which affect kidney outcomes. If you or a family member with CKD notices memory trouble, confusion with medications, or difficulty keeping track of medical instructions, raising it with the care team is important. Screening for cognitive impairment is not yet routine in nephrology clinics, but the evidence increasingly suggests it should be.